| Financial Year |
March 31 2023 |
| Monetary Funds |
730,711,914.39 |
| Held-for-trading Financial Assets |
258,440,541.67 |
| Notes Receivable |
2,098,300.00 |
| Accounts Receivable |
201,298,774.62 |
| Advances to Suppliers |
31,034,033.50 |
| Other Receivables |
26,702,586.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
190,249,415.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,476,177.14 |
| Total Current Assets |
1,591,450,840.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,110,665.69 |
| Investment Properties |
52,662,477.46 |
| Fixed Assetes |
190,837,067.47 |
| Under-construction Projects |
743,150.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,821,066.00 |
| R&D expenses |
566,598.28 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,072,595.99 |
| Deferred Income Tax Assets |
1,494,740.37 |
| Other Non-Current Assets |
72,018,211.70 |
| Sub-Total of Non-Current Assets |
808,184,568.66 |
| Total Assets |
2,399,635,408.74 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
134,026,301.22 |
| Accounts Received In Advance |
2,190,370.51 |
| Employee Compensation Payable |
36,564,004.05 |
| Taxes Payable |
1,141,933.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,128,034.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,688,045.75 |
| Other Current Liabilities |
9,809,338.55 |
| Sub-Total of Current Liabilities |
405,386,263.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
95,596,214.47 |
| Total Liabilities |
500,982,478.30 |
| Paid-In Capital(Or Share Stock) |
576,000,000.00 |
| Capital Surplus |
245,140,532.64 |
| Surplus Reserve |
138,639,593.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
954,989,396.52 |
| Minority Stockholder's Interest |
27,243,180.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,871,409,749.94 |
| Owner's Equity（Stockholder's Equity） |
1,898,652,930.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,399,635,408.74 |
